Back to
FMR LLC
SRPT28 quarters
Position history for
FMR LLC's holdings in SAREPTA THERAPEUTICS INC
Yes. FMR holds 237,042 shares of SRPT (Sarepta Therapeutics), worth $4.3M, as of its Q2 2026 13F filing. It increased the position from 14,545 shares in Q1 2026. FMR has held SRPT in every 13F on record since Q3 2019, 28 quarterly filings.
Current Value
$4.3M
Current Shares
237,042
Total Value Change
-$603M
Total Shares Change
-7.8M
Quarter-by-Quarter History
Other major holders of SRPT: BlackRock Finance, Inc., BlackRock, Inc., Capital Research Global Investors, VANGUARD GROUP INC